This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4jfe
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a melanoma-specific TCR== | ==Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a melanoma-specific TCR== | ||
<StructureSection load='4jfe' size='340' side='right' caption='[[4jfe]], [[Resolution|resolution]] 2.70Å' scene=''> | <StructureSection load='4jfe' size='340' side='right' caption='[[4jfe]], [[Resolution|resolution]] 2.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4jfe]] is a 5 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[4jfe]] is a 5 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4JFE OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4JFE FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4jfd|4jfd]], [[4jff|4jff]], [[4jfh|4jfh]], [[4jfo|4jfo]], [[4jfp|4jfp]], [[4jfq|4jfq]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4jfd|4jfd]], [[4jff|4jff]], [[4jfh|4jfh]], [[4jfo|4jfo]], [[4jfp|4jfp]], [[4jfq|4jfq]]</td></tr> | ||
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">HLA-A, HLAA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">HLA-A, HLAA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN]), B2M, CDABP0092, HDCMA22P ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4jfe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4jfe OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4jfe RCSB], [http://www.ebi.ac.uk/pdbsum/4jfe PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4jfe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4jfe OCA], [http://pdbe.org/4jfe PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4jfe RCSB], [http://www.ebi.ac.uk/pdbsum/4jfe PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4jfe ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
| Line 20: | Line 21: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4jfe" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
| Line 28: | Line 30: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Human]] |
[[Category: Cole, D K]] | [[Category: Cole, D K]] | ||
[[Category: Madura, F]] | [[Category: Madura, F]] | ||
Revision as of 14:55, 5 August 2016
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a melanoma-specific TCR
| |||||||||||
Categories: Human | Cole, D K | Madura, F | Rizkallah, P J | Sewell, A K | High affinity | Hla | Immune system | Melanoma | Tcr
